Select language:  
1800 620 420
Close menu

Blood Cancer Taskforce unveils new Optimal Care Pathways for blood cancer treatment and care

Australia’s Blood Cancer Taskforce today released five new Optimal Care Pathways (OCPs), marking a significant advancement for blood cancer treatment and care in Australia.

Read more

Talking Blood Cancer: Finding Strength

Join Nerys Welch's journey through acute myeloid leukaemia (AML) / acute lymphoblastic leukaemia (ALL) loss and parenting 3 kids. Discover her solace in the Leukaemia Foundation's supportive online community.

  • Acute lymphoblastic leukaemia
  • Acute myeloid leukaemia
Read more

Treatment and transplant news

Once a blood cancer treatment is developed, it needs to be approved for sale in Australia and subsidised, or ‘listed’, otherwise the cost for the treatment can be unaffordable for many patients. The Medical Services Advisory Committee (MSAC) or Pharmaceutical Benefits Advisory Committee (PBAC) appraises a new treatment and provides advice to the Government on whether it should be publicly funded. This includes seeking consumer comments. Here’s a summary of recent new and recommended listings for blood cancer treatments. The Leukaemia Foundation provided advice and consumer comments to PBAC/MSAC in support of these therapies being available to patients.

  • Advocacy and policy
  • Treatments and side-effects
Read more

Blood cancer ride proves Perry’s toughest race

As Perry Judd slowly pedalled over the finishing line at the prestigious Grafton to Inverell Cycle Classic in 2013, supposedly in the form of his life but somehow lagging far behind the competition, he knew something wasn’t right. Physically exhausted, Perry feared he had glandular fever, but a blood test revealed something much more dangerous. The then 37-year-old explained: “I had a call from the GP: ‘Please come and see me, we need to talk urgently. You need to come in right away’.

  • Acute myeloid leukaemia
  • Treatments and side-effects
Read more

Hon. Anna Bligh AC Joins Leukaemia Foundation as National Ambassador

The Leukaemia Foundation today unveiled a powerful addition to its team of Ambassadors, the Honourable Anna Bligh AC. As the former Premier of Queensland and current CEO of the Australian Banking Association, Ms Bligh is a survivor of the blood cancer Non-Hodgkin lymphoma, after being diagnosed in 2013. Ms Bligh will immediately step into her role as National Ambassador, bringing with her a wealth of experience to passionately advocate for fellow Australians impacted by blood cancer.

  • Media releases
  • Non-Hodgkin lymphoma
Read more
Hon. Anna Bligh AC

Talking Blood Cancer: Mother-Daughter Cancer Warriors

Join Kate Arkadieff and Theresa Webb as they delve into non-Hodgkin's lymphoma & acute lymphoblastic leukaemia (leukemia) journeys for patients and families on the Talking Blood Cancer podcast by Leukaemia Foundation.

  • Acute lymphoblastic leukaemia
  • Non-Hodgkin lymphoma
Read more

The biggest challenge of cancer patients that nobody talks about…

It’s the number one challenge of people with cancer in Australia , yet ‘cancer related fatigue’ is the often-unspoken side effect that drains and debilitates thousands of Australians every day. With approximately one in two cancer patients reportedly experiencing moderate to severe fatigue during treatment , and for many in the years following, the Leukaemia Foundation believes the prevalence of cancer related fatigue could be much higher.

Read more

Physiotherapist and lymphoma survivor Julie Allen on cancer related fatigue

Discover how physiotherapist Julie Allen tackles cancer fatigue and lymphoma, enhancing the quality of life and survival for blood cancer patients.

  • Interviews with experts
  • Non-Hodgkin lymphoma
Read more

Unlocking the Mysteries of Blood Cancer

In the ever-evolving landscape of blood cancer research, the quest to combat blood cancer continues to push boundaries. The New Directions in Leukaemia Research (NDLR) event in Adelaide last month brought together leading minds in the field to discuss breakthroughs, challenges, and the future of leukaemia treatment. From cutting-edge advancements in therapies to the promise of personalised medicine, the conference, sponsored by the Leukaemia Foundation, shed light on the latest discoveries and strategies shaping the fight against leukaemia.

  • Research
Read more

Theresa Webb: ‘I’ve always been a survivor’

Blood cancer casts a long shadow over many Australian families, but for Theresa Webb and her family, its shadow has been longer than most. Theresa was first diagnosed with blood cancer in 2002 after discovering a small hard lump near her collarbone. A biopsy revealed the then 30-year-old had a type of blood cancer called non-Hodgkin lymphoma.

  • Acute lymphoblastic leukaemia
  • Carers
  • Lifestyle and living well
  • Non-Hodgkin lymphoma
Read more
Theresa with her daughters, Summer and Jessi, on the day of her stem cell transplant